about
Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension.Association between hemoglobin level and endothelial function in uncomplicated, untreated hypertensive patientsAdditive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients.Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure.Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure.Serum phosphorus levels are associated with endothelial dysfunction in hypertensive patients.Risk reclassification ability of uric acid for cardiovascular outcomes in essential hypertension.Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension.Serum alkaline phosphatase negatively affects endothelium-dependent vasodilation in naïve hypertensive patients.Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients.Uric acid is an independent predictor of cardiovascular events in post-menopausal women.Insulin-resistance HCV infection-related affects vascular stiffness in normotensives.Chronic HCV infection increases cardiac left ventricular mass index in normotensive patients.Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients.Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients.Endothelial dysfunction predicts regression of hypertensive cardiac mass.Endothelial dysfunction, ADMA and insulin resistance in essential hypertension.Pulse pressure and endothelial dysfunction in never-treated hypertensive patients.Creatinine and insulin predict cardiac mass in drug-naïve hypertensive patients.Endothelial dysfunction and mild renal insufficiency in essential hypertension.Interaction between uric acid and endothelial dysfunction predicts new onset of diabetes in hypertensive patients.Uric acid and endothelial dysfunction in essential hypertension.Phenotypic characterization of normotolerant hypertensive patients.Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects.Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension.Prevalence of Delirium in a Population of Elderly Outpatients with Dementia: A Retrospective Study.Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women.Inflammation as a Mediator of the Link between Mild to Moderate Renal Insufficiency and Endothelial Dysfunction in Essential HypertensionOxidative Stress Impairs Endothelial Function in Nondipper Hypertensive PatientsRole of PC-1 and ACE genes on insulin resistance and cardiac mass in never-treated hypertensive patients. Suggestive evidence for a digenic additive modulationEvaluation of antihypertensive effects of once-a-day isradipine and fosinopril: a double-blind crossover study by means of ambulatory blood pressure monitoringHypertensive left ventricular remodeling and ACE-gene polymorphismEffects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patientsAngiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patientsRelationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patientsCalcium antagonist isradipine improves abnormal endothelium-dependent vasodilation in never treated hypertensive patientsHeart rate affects endothelial function in essential hypertensionOne-hour post-load plasma glucose and IGF-1 in hypertensive patientsMetabolic and vascular effects of silybin in hypertensive patients with high 1-h post-load plasma glucose
P50
Q34427106-85EB2459-B534-4874-9FF1-DFB82179C2F8Q34858081-25C71DF8-F7EF-45BF-824F-BBB1A3432498Q36846905-3A085509-A03A-4BED-84EC-5A59518EE833Q37801830-874AAAC0-ECE6-43B5-BFDA-DAF09C5DB81BQ39199887-C81D94D1-7F7D-4F81-BEC5-0954F798C50BQ39829535-851C18EF-9FE8-4DC9-A5FE-A0E78A7AC321Q40191780-4D66AF84-89CB-4F12-B525-B4782C19808CQ40448775-3CBAFBBB-2AC4-4A6F-85C2-95B6AF76F3D4Q40589070-B28E6156-774C-46F0-828F-6DB9D8A39870Q41153540-25E27F08-FA54-406F-90BB-B56FD6866338Q41612532-2BDF8453-C615-4E47-A3D5-545AEC25348FQ41626112-6C11AB41-D198-443D-8291-AF7D6B883FA6Q42215534-EF42D277-CFA3-409F-B1E5-11948E45309BQ42972391-0DA158D0-0700-4740-A0C2-B78605345320Q43421825-EF920593-104B-4F09-A0D5-D6B0488CA291Q43630539-800B87FD-11B4-4574-991F-987E5A0D55C2Q44134860-20E5AD21-9C48-459D-B2B6-FF06564AB018Q44454560-E50F2D61-5469-401E-A675-F96285024FADQ44778115-4DC4FC8B-9F8E-4330-8123-3F788DE3C77BQ45004035-22B6C48D-B5EE-4261-AD18-045098FCB2E4Q45019020-6CFD1749-6F56-413B-825A-33AFBF002A5CQ45089220-EC8A0B47-6C8F-4C10-8A7D-B33D3DF3A0FCQ45145336-7958A443-2D6F-4ABF-B634-7CB73C2B0C13Q46626286-19C28533-8577-4D23-A583-93C5B7C46382Q46631372-68D3D973-4431-4E67-8EB2-BB574BB5D189Q46635483-3282D336-8F66-4FCD-A9A2-63DA1964A32CQ47419328-7C25F43F-9626-491D-A6FD-F1D1EC2BAA2AQ51819816-246594D9-55EF-464E-943A-110F43B859ACQ58949602-6896DF05-A48C-449D-B946-153BCDACA438Q60231372-3C6E9410-5B52-46EB-8245-36C33036A6F7Q60231376-012C5280-E600-4780-AE48-298BA3785545Q71731213-118DA2BB-1DAA-48AC-9A5B-4EACB789168FQ73120017-8C0F15C4-01C0-4B7D-A540-101CB08FC4D1Q74348251-52DEB521-3F0A-4DAC-9CA6-449C93B6AEE6Q74423534-F9CF5B9D-C523-44A1-BEE6-6A088E5CAF03Q77342556-82829A11-9C28-4640-B5FC-94A87AF092F6Q77746065-981B39CB-2E7C-4619-8EEA-D15FBE1B6548Q84074449-9C71F359-98D2-4D5F-9E81-04B576E503C9Q85221227-8C8B0B85-E651-4C70-96EB-A94B2C026D3FQ91558386-CAB02A8A-B158-4227-83C8-58C10641F3C4
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Raffaele Maio
@ast
Raffaele Maio
@en
Raffaele Maio
@es
Raffaele Maio
@nl
type
label
Raffaele Maio
@ast
Raffaele Maio
@en
Raffaele Maio
@es
Raffaele Maio
@nl
prefLabel
Raffaele Maio
@ast
Raffaele Maio
@en
Raffaele Maio
@es
Raffaele Maio
@nl
P106
P1153
7006745346
P21
P31
P496
0000-0002-7290-9470